Shanghai launched a new special campaign and issued coupons again! The civilized market and supporting promotion in Wujiaochang business district lasted for 10 days. On December 13th, the special action of "Going to the Covenant of Civilizations" by civilized units in Shanghai to help the joint development of cultural and sports tourism and business exhibitions was launched. The first stop was opened in Wujiaochang, Yangpu District, and it was divided into three sections: civilized market, flash stage and supporting promotion, which will last for 10 days. After mobilization and negotiation, merchants and enterprises in Wujiaochang Business Circle, Daxue Road and Guohua Plaza jointly launched a number of exclusive coupons for "Going to the Covenant of Civilization" during the event, including more than 30,000 limited coupons and 18 unlimited coupons, covering restaurants, food, beauty and clothing, and fashionable life businesses, which not only brought tangible benefits to the citizens, but also helped the business circle to drain and develop the real economy. The citizens can check the H5 activity page through the "Shanghai Yangpu" WeChat WeChat official account, and grab coupons and write them off at 10:00 every day from December 13th to 22nd. (Watch the news)Kexing launched the world's first phase III clinical study of bivalent inactivated enterovirus vaccine. On December 13th, the first volunteer was enrolled in the phase III clinical study of bivalent inactivated enterovirus vaccine developed by Beijing Kexing Biological Products Co., Ltd., a subsidiary of Kexing Holding Biotechnology Co., Ltd. (hereinafter referred to as "Kexing"). The vaccine is used to prevent hand, foot and mouth disease caused by enterovirus 71 (EV71) and coxsackie virus 16 (CA16). A multicenter, randomized, double-blind, controlled study design was adopted in this phase III clinical study to evaluate the protective efficacy, safety and immunogenicity of the vaccine in children aged 6-71 months.Jinghe Jicheng: Shareholder Lijing Venture Capital intends to transfer 1.50% shares of the company by inquiry, and Jinghe Jicheng announced that shareholder Lijing Venture Capital intends to transfer 30.092 million shares of the company by inquiry transfer, accounting for 1.50% of the company's total share capital.
Market News: The United Arab Emirates will restrict oil transportation in the case of OPEC+promoting compliance with quotas.As a result of providing loans with private fund property, Haisi Quanzong's private placement and responsible person were supervised to issue a warning letter. On December 13th, Qingdao Securities Regulatory Bureau issued a notice saying that after investigation, Qingdao Haisi Quanzong Private Fund Management Co., Ltd. (hereinafter referred to as "Haisi Quanzong Private Placement") provided loans with private fund property, which violated the regulations. Song Xiuhong was then the legal representative and chairman of Haisi Quanzong Private Equity, and Liu Jialiang is now the legal representative and chairman of Haisi Quanzong Private Equity. Since the establishment of Haisi Quanzong Private Equity, Wang Zhaohui has been the general manager. During his tenure, he failed to fulfill his duties and strictly abide by laws and regulations, and was responsible for the above acts. Qingdao Securities Regulatory Bureau took administrative supervision measures to issue warning letters to Haisi Quanzong Private Equity, Song Xiuhong, Liu Jialiang and Wang Chaohui.Yunnan Nengtou: It is planned to invest in Yongning wind farm expansion project. Yunnan Nengtou announced that Maitreya Company, a wholly-owned subsidiary, plans to invest in Yongning wind farm expansion project (Maitreya area), with a total installed capacity of 230,000 kilowatts and a total investment of 1.323 billion yuan (including 6.9 million yuan in working capital). On the same day, it was announced that Honghe Company, a wholly-owned subsidiary, planned to invest in the Yongning Wind Farm Expansion Project (Luxi Area), with a total installed capacity of 235,000 kilowatts and a total investment of 1.395 billion yuan (including 7.05 million yuan in working capital).
Kexing launched the world's first phase III clinical study of bivalent inactivated enterovirus vaccine. On December 13th, the first volunteer was enrolled in the phase III clinical study of bivalent inactivated enterovirus vaccine developed by Beijing Kexing Biological Products Co., Ltd., a subsidiary of Kexing Holding Biotechnology Co., Ltd. (hereinafter referred to as "Kexing"). The vaccine is used to prevent hand, foot and mouth disease caused by enterovirus 71 (EV71) and coxsackie virus 16 (CA16). A multicenter, randomized, double-blind, controlled study design was adopted in this phase III clinical study to evaluate the protective efficacy, safety and immunogenicity of the vaccine in children aged 6-71 months.Sources: Russia has suspended grain exports to Syria. Russian and Syrian sources said on Friday that Russia's wheat supply to Syria has been suspended due to the uncertainty of the new Syrian government and the delay in payment.Bei Ya raised the Amazon target price from $220.00 to $260.00.
Strategy guide
12-14
Strategy guide 12-14
Strategy guide
Strategy guide 12-14